|
Insider Trading: Cytokinetics Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cytokinetics Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Cytokinetics Inc since year 2005. Table 2 shows the detailed insider transactions of Cytokinetics Inc since 2005.
The reporting company's ticker symbol is CYTK.
The reporting company's CIK number is 1061983.
The total value of stock buying since 2005 is $603,882.
The total value of stock sales is $4,389,025.
The total value of stock exercises is $482,684.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Cytokinetics Inc (CYTK) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 -
Figure 2. Average prices of insider buys, sales, and option exercises at Cytokinetics Inc (CYTK) in the past 24 months. See table 2 for insider transaction details.
10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Cytokinetics Inc (CYTK).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-08 | 0 | 0 | 14,976 | 77,758 | 13,565 | 16,277 |
| 2008-07 | 0 | 0 | 20,651 | 103,255 | 13,302 | 26,604 |
| 2008-04 | 0 | 0 | 2,000 | 6,630 | 0 | 0 |
| 2008-03 | 0 | 0 | 2,000 | 6,770 | 0 | 0 |
| 2008-02 | 0 | 0 | 2,000 | 7,000 | 0 | 0 |
| 2008-01 | 0 | 0 | 3,000 | 13,559 | 0 | 0 |
| 2007-12 | 0 | 0 | 16,702 | 88,033 | 13,702 | 21,804 |
| 2007-11 | 0 | 0 | 23,814 | 120,932 | 20,814 | 36,028 |
| 2007-10 | 0 | 0 | 31,656 | 171,157 | 22,656 | 39,712 |
| 2007-09 | 0 | 0 | 22,874 | 114,338 | 41,874 | 58,148 |
| 2007-08 | 20,000 | 101,420 | 23,045 | 116,894 | 50,045 | 56,614 |
| 2007-07 | 0 | 0 | 22,582 | 122,905 | 7,327 | 8,588 |
| 2007-06 | 0 | 0 | 30,725 | 192,434 | 34,500 | 39,230 |
| 2007-05 | 0 | 0 | 7,800 | 52,001 | 0 | 0 |
| 2007-04 | 0 | 0 | 1,500 | 10,578 | 0 | 0 |
| 2007-03 | 0 | 0 | 1,500 | 10,680 | 0 | 0 |
| 2007-02 | 0 | 0 | 8,500 | 67,217 | 7,000 | 8,400 |
| 2007-01 | 0 | 0 | 15,200 | 129,008 | 12,000 | 14,400 |
| 2006-12 | 0 | 0 | 15,200 | 108,418 | 12,000 | 9,130 |
| 2006-11 | 0 | 0 | 25,200 | 188,965 | 22,000 | 15,859 |
| 2006-10 | 0 | 0 | 30,200 | 201,569 | 27,000 | 18,759 |
| 2006-09 | 0 | 0 | 20,200 | 137,727 | 17,000 | 12,959 |
| 2006-08 | 0 | 0 | 24,199 | 143,803 | 21,999 | 15,858 |
| 2006-07 | 0 | 0 | 24,197 | 144,395 | 21,997 | 15,856 |
| 2006-06 | 0 | 0 | 15,195 | 102,476 | 11,995 | 6,956 |
| 2006-05 | 0 | 0 | 30,063 | 214,430 | 26,863 | 18,678 |
| 2006-04 | 0 | 0 | 26,867 | 200,806 | 23,667 | 15,825 |
| 2006-03 | 0 | 0 | 24,263 | 171,453 | 21,063 | 14,315 |
| 2006-02 | 40,000 | 290,187 | 20,450 | 148,737 | 18,250 | 12,684 |
| 2005-11 | 0 | 0 | 158,900 | 1,215,097 | 0 | 0 |
| 2004-04 | 25,000 | 212,275 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Cytokinetics Inc (CYTK)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-08-29 | Blum Robert I (President & CEO) | Sale | 9,676 | 5.30 | 51,258 |
| 2008-08-29 | Blum Robert I (President & CEO) | Option Exercise | 9,676 | 1.20 | 11,611 |
| 2008-08-15 | Blum Robert I (President & CEO) | Sale | 5,300 | 5.00 | 26,500 |
| 2008-08-15 | Blum Robert I (President & CEO) | Option Exercise | 3,889 | 1.20 | 4,666 |
| 2008-07-31 | Blum Robert I (President & CEO) | Sale | 20,651 | 5.00 | 103,255 |
| 2008-07-31 | Blum Robert I (President & CEO) | Option Exercise | 13,302 | 2.00 | 26,604 |
| 2008-04-25 | Spudich James A (Director) | Sale | 2,000 | 3.32 | 6,630 |
| 2008-03-20 | Spudich James A (Director) | Sale | 2,000 | 3.38 | 6,770 |
| 2008-02-27 | Spudich James A (Director) | Sale | 2,000 | 3.50 | 7,000 |
| 2008-01-08 | Spudich James A (Director) | Sale | 3,000 | 4.52 | 13,559 |
| 2007-12-14 | Blum Robert I (President & CEO) | Sale | 6,702 | 5.39 | 36,123 |
| 2007-12-14 | Blum Robert I (President & CEO) | Option Exercise | 6,702 | 2.00 | 13,404 |
| 2007-12-10 | Spudich James A (Director) | Sale | 3,000 | 5.64 | 16,910 |
| 2007-12-03 | Sabry James H (Executive Chairman) | Sale | 7,000 | 5.00 | 35,000 |
| 2007-12-03 | Sabry James H (Executive Chairman) | Option Exercise | 7,000 | 1.20 | 8,400 |
| 2007-11-30 | Blum Robert I (President & CEO) | Sale | 6,805 | 5.19 | 35,317 |
| 2007-11-30 | Blum Robert I (President & CEO) | Option Exercise | 6,805 | 2.00 | 13,610 |
| 2007-11-15 | Blum Robert I (President & CEO) | Sale | 7,009 | 5.00 | 35,045 |
| 2007-11-15 | Blum Robert I (President & CEO) | Option Exercise | 7,009 | 2.00 | 14,018 |
| 2007-11-02 | Spudich James A (Director) | Sale | 3,000 | 5.19 | 15,570 |
| 2007-11-01 | Sabry James H (Executive Chairman) | Sale | 7,000 | 5.00 | 35,000 |
| 2007-11-01 | Sabry James H (Executive Chairman) | Option Exercise | 7,000 | 1.20 | 8,400 |
| 2007-10-31 | Blum Robert I (President & CEO) | Sale | 7,419 | 5.03 | 37,317 |
| 2007-10-31 | Blum Robert I (President & CEO) | Option Exercise | 7,419 | 2.00 | 14,838 |
| 2007-10-15 | Blum Robert I (President & CEO) | Sale | 8,237 | 6.05 | 49,810 |
| 2007-10-15 | Blum Robert I (President & CEO) | Option Exercise | 8,237 | 2.00 | 16,474 |
| 2007-10-03 | Spudich James A (Director) | Sale | 6,000 | 5.41 | 32,464 |
| 2007-10-01 | Sabry James H (Executive Chairman) | Sale | 7,000 | 5.05 | 35,334 |
| 2007-10-01 | Sabry James H (Executive Chairman) | Option Exercise | 7,000 | 1.20 | 8,400 |
| 2007-09-28 | Blum Robert I (President & CEO) | Sale | 9,874 | 5.09 | 50,258 |
| 2007-09-28 | Blum Robert I (President & CEO) | Option Exercise | 9,874 | 2.00 | 19,748 |
| 2007-09-28 | Morgans David J Jr (SVP-Preclinical R&D) | Sale | 5,000 | 5.09 | 25,450 |
| 2007-09-14 | Morgans David J Jr (SVP-Preclinical R&D) | Sale | 5,000 | 4.75 | 23,750 |
| 2007-09-14 | Morgans David J Jr (SVP-Preclinical R&D) | Option Exercise | 32,000 | 1.20 | 38,400 |
| 2007-09-05 | Spudich James A (Director) | Sale | 3,000 | 4.96 | 14,880 |
| 2007-08-30 | Blum Robert I (President & CEO) | Sale | 6,548 | 5.11 | 33,460 |
| 2007-08-30 | Blum Robert I (President & CEO) | Option Exercise | 6,548 | 1.29 | 8,446 |
| 2007-08-17 | Dow Stephen M | Purchase | 20,000 | 5.07 | 101,420 |
| 2007-08-15 | Blum Robert I (President & CEO) | Sale | 6,497 | 5.04 | 32,744 |
| 2007-08-15 | Blum Robert I (President & CEO) | Option Exercise | 6,497 | .58 | 3,768 |
| 2007-08-10 | Trautman Jay K (VP, Discovery Research) | Option Exercise | 30,000 | 1.20 | 36,000 |
| 2007-08-02 | Spudich James A (Director) | Sale | 3,000 | 5.23 | 15,690 |
| 2007-08-01 | Sabry James H (Executive Chairman) | Sale | 7,000 | 5.00 | 35,000 |
| 2007-08-01 | Sabry James H (Executive Chairman) | Option Exercise | 7,000 | 1.20 | 8,400 |
| 2007-07-31 | Blum Robert I (President & CEO) | Sale | 6,394 | 5.00 | 31,970 |
| 2007-07-31 | Blum Robert I (President & CEO) | Option Exercise | 267 | .58 | 154 |
| 2007-07-16 | Blum Robert I (President & CEO) | Sale | 6,188 | 5.48 | 33,910 |
| 2007-07-16 | Blum Robert I (President & CEO) | Option Exercise | 60 | .58 | 34 |
| 2007-07-03 | Spudich James A (Director) | Sale | 3,000 | 5.68 | 17,055 |
| 2007-07-02 | Sabry James H (Executive Chairman) | Sale | 7,000 | 5.71 | 39,970 |
| 2007-07-02 | Sabry James H (Executive Chairman) | Option Exercise | 7,000 | 1.20 | 8,400 |
| 2007-06-29 | Blum Robert I (President & CEO) | Sale | 5,775 | 5.86 | 33,867 |
| 2007-06-29 | Morgans David J Jr (SVP-Preclinical R&D) | Sale | 5,000 | 6.00 | 30,000 |
| 2007-06-15 | Blum Robert I (President & CEO) | Sale | 4,950 | 6.46 | 31,977 |
| 2007-06-15 | Morgans David J Jr (SVP-Preclinical R&D) | Sale | 5,000 | 6.46 | 32,300 |
| 2007-06-15 | Morgans David J Jr (SVP-Preclinical R&D) | Option Exercise | 27,500 | 1.20 | 33,000 |
| 2007-06-11 | Sabry James H (Executive Chairman) | Sale | 7,000 | 6.39 | 44,730 |
| 2007-06-11 | Sabry James H (Executive Chairman) | Option Exercise | 7,000 | .89 | 6,230 |
| 2007-06-04 | Spudich James A (Director) | Sale | 3,000 | 6.52 | 19,560 |
| 2007-05-29 | Blum Robert I (President & CEO) | Sale | 3,300 | 6.50 | 21,461 |
| 2007-05-11 | Spudich James A (Director) | Sale | 3,000 | 6.68 | 20,025 |
| 2007-05-10 | Trautman Jay K (VP, Discovery Research) | Sale | 1,500 | 7.01 | 10,515 |
| 2007-04-10 | Trautman Jay K (VP, Discovery Research) | Sale | 1,500 | 7.05 | 10,578 |
| 2007-03-09 | Trautman Jay K (VP, Research) | Sale | 1,500 | 7.12 | 10,680 |
| 2007-02-09 | Trautman Jay K (VP, Research) | Sale | 1,500 | 8.00 | 12,000 |
| 2007-02-01 | Sabry James H (CEO) | Sale | 7,000 | 7.89 | 55,217 |
| 2007-02-01 | Sabry James H (CEO) | Option Exercise | 7,000 | 1.20 | 8,400 |
| 2007-01-16 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Sale | 5,000 | 8.31 | 41,550 |
| 2007-01-16 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Option Exercise | 5,000 | 1.20 | 6,000 |
| 2007-01-11 | Spudich James A (Director) | Sale | 2,200 | 8.32 | 18,293 |
| 2007-01-11 | Trautman Jay K (VP, Research) | Sale | 1,000 | 8.30 | 8,300 |
| 2007-01-03 | Sabry James H (CEO) | Sale | 7,000 | 8.70 | 60,865 |
| 2007-01-03 | Sabry James H (CEO) | Option Exercise | 7,000 | 1.20 | 8,400 |
| 2006-12-21 | Spudich James A (Director) | Sale | 2,200 | 6.83 | 15,033 |
| 2006-12-15 | Blum Robert I (President) | Sale | 5,000 | 6.94 | 34,700 |
| 2006-12-15 | Blum Robert I (President) | Option Exercise | 5,000 | .58 | 2,900 |
| 2006-12-11 | Trautman Jay K (VP, Research) | Sale | 1,000 | 7.30 | 7,300 |
| 2006-12-01 | Sabry James H (CEO) | Sale | 7,000 | 7.34 | 51,385 |
| 2006-12-01 | Sabry James H (CEO) | Option Exercise | 7,000 | .89 | 6,230 |
| 2006-11-30 | Blum Robert I (President) | Sale | 5,000 | 7.29 | 36,468 |
| 2006-11-30 | Blum Robert I (President) | Option Exercise | 5,000 | .58 | 2,900 |
| 2006-11-21 | Spudich James A (Director) | Sale | 2,200 | 7.73 | 17,013 |
| 2006-11-15 | Blum Robert I (President) | Sale | 5,000 | 7.62 | 38,094 |
| 2006-11-15 | Blum Robert I (President) | Option Exercise | 5,000 | .58 | 2,900 |
| 2006-11-15 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Sale | 5,000 | 7.80 | 39,000 |
| 2006-11-15 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Option Exercise | 5,000 | 1.20 | 6,000 |
| 2006-11-10 | Trautman Jay K (VP, Research) | Sale | 1,000 | 7.29 | 7,290 |
| 2006-11-01 | Sabry James H (CEO) | Sale | 7,000 | 7.30 | 51,100 |
| 2006-11-01 | Sabry James H (CEO) | Option Exercise | 7,000 | .58 | 4,059 |
| 2006-10-30 | Blum Robert I (President) | Sale | 5,000 | 7.02 | 35,075 |
| 2006-10-30 | Blum Robert I (President) | Option Exercise | 5,000 | .58 | 2,900 |
| 2006-10-24 | Spudich James A (Director) | Sale | 2,200 | 7.02 | 15,433 |
| 2006-10-19 | Trautman Jay K (VP, Research) | Sale | 1,000 | 7.00 | 7,000 |
| 2006-10-16 | Blum Robert I (President) | Sale | 5,000 | 6.75 | 33,747 |
| 2006-10-16 | Blum Robert I (President) | Option Exercise | 5,000 | .58 | 2,900 |
| 2006-10-13 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Sale | 5,000 | 6.67 | 33,350 |
| 2006-10-13 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Option Exercise | 5,000 | 1.20 | 6,000 |
| 2006-10-02 | Blum Robert I (President) | Sale | 5,000 | 6.38 | 31,884 |
| 2006-10-02 | Blum Robert I (President) | Option Exercise | 5,000 | .58 | 2,900 |
| 2006-10-02 | Sabry James H (President and CEO) | Sale | 7,000 | 6.44 | 45,080 |
| 2006-10-02 | Sabry James H (President and CEO) | Option Exercise | 7,000 | .58 | 4,059 |
| 2006-09-29 | Spudich James A (Director) | Sale | 2,200 | 6.48 | 14,267 |
| 2006-09-15 | Blum Robert I (President) | Sale | 5,000 | 6.77 | 33,830 |
| 2006-09-15 | Blum Robert I (President) | Option Exercise | 5,000 | .58 | 2,900 |
| 2006-09-15 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Sale | 5,000 | 7.02 | 35,100 |
| 2006-09-15 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Option Exercise | 5,000 | 1.20 | 6,000 |
| 2006-09-12 | Trautman Jay K (VP, Research) | Sale | 1,000 | 7.00 | 7,000 |
| 2006-09-01 | Sabry James H (President and CEO) | Sale | 7,000 | 6.79 | 47,530 |
| 2006-09-01 | Sabry James H (President and CEO) | Option Exercise | 7,000 | .58 | 4,059 |
| 2006-08-30 | Blum Robert I (President) | Sale | 5,000 | 6.44 | 32,200 |
| 2006-08-30 | Blum Robert I (President) | Option Exercise | 5,000 | .58 | 2,900 |
| 2006-08-25 | Spudich James A (Director) | Sale | 2,200 | 6.07 | 13,357 |
| 2006-08-18 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Sale | 5,000 | 6.00 | 30,000 |
| 2006-08-18 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Option Exercise | 5,000 | 1.20 | 6,000 |
| 2006-08-15 | Blum Robert I (President) | Sale | 4,999 | 5.45 | 27,261 |
| 2006-08-15 | Blum Robert I (President) | Option Exercise | 4,999 | .58 | 2,899 |
| 2006-08-01 | Sabry James H (President and CEO) | Sale | 7,000 | 5.86 | 40,985 |
| 2006-08-01 | Sabry James H (President and CEO) | Option Exercise | 7,000 | .58 | 4,059 |
| 2006-07-31 | Blum Robert I (President) | Sale | 4,999 | 5.63 | 28,126 |
| 2006-07-31 | Blum Robert I (President) | Option Exercise | 4,999 | .58 | 2,899 |
| 2006-07-26 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Sale | 3,490 | 6.00 | 20,940 |
| 2006-07-26 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Option Exercise | 3,490 | 1.20 | 4,188 |
| 2006-07-25 | Spudich James A (Director) | Sale | 2,200 | 5.88 | 12,940 |
| 2006-07-25 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Sale | 1,510 | 6.00 | 9,060 |
| 2006-07-25 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Option Exercise | 1,510 | 1.20 | 1,812 |
| 2006-07-17 | Blum Robert I (President) | Sale | 4,998 | 5.52 | 27,563 |
| 2006-07-17 | Blum Robert I (President) | Option Exercise | 4,998 | .58 | 2,898 |
| 2006-07-03 | Sabry James H (President and CEO) | Sale | 7,000 | 6.54 | 45,766 |
| 2006-07-03 | Sabry James H (President and CEO) | Option Exercise | 7,000 | .58 | 4,059 |
| 2006-06-30 | Blum Robert I (President) | Sale | 4,995 | 6.61 | 33,016 |
| 2006-06-30 | Blum Robert I (President) | Option Exercise | 4,995 | .58 | 2,897 |
| 2006-06-29 | Spudich James A (Director) | Sale | 2,200 | 6.49 | 14,278 |
| 2006-06-09 | Trautman Jay K (VP, Research) | Sale | 1,000 | 7.03 | 7,030 |
| 2006-06-01 | Sabry James H (President and CEO) | Sale | 7,000 | 6.88 | 48,152 |
| 2006-06-01 | Sabry James H (President and CEO) | Option Exercise | 7,000 | .58 | 4,059 |
| 2006-05-30 | Blum Robert I (President) | Sale | 4,980 | 7.06 | 35,158 |
| 2006-05-30 | Blum Robert I (President) | Option Exercise | 4,980 | .58 | 2,888 |
| 2006-05-22 | Spudich James A (Director) | Sale | 2,200 | 7.29 | 16,038 |
| 2006-05-15 | Blum Robert I (President) | Sale | 4,961 | 6.99 | 34,676 |
| 2006-05-15 | Blum Robert I (President) | Option Exercise | 4,961 | .58 | 2,877 |
| 2006-05-15 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Sale | 5,000 | 7.03 | 35,150 |
| 2006-05-15 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Option Exercise | 5,000 | 1.20 | 6,000 |
| 2006-05-10 | Trautman Jay K (VP, Research) | Sale | 1,000 | 7.87 | 7,870 |
| 2006-05-01 | Blum Robert I (EVP, Corp. Development & CBO) | Sale | 4,922 | 7.17 | 35,278 |
| 2006-05-01 | Blum Robert I (EVP, Corp. Development & CBO) | Option Exercise | 4,922 | .58 | 2,854 |
| 2006-05-01 | Sabry James H (President and CEO) | Sale | 7,000 | 7.18 | 50,260 |
| 2006-05-01 | Sabry James H (President and CEO) | Option Exercise | 7,000 | .58 | 4,059 |
| 2006-04-17 | Blum Robert I (EVP, Corp. Development & CBO) | Sale | 4,844 | 7.34 | 35,554 |
| 2006-04-17 | Blum Robert I (EVP, Corp. Development & CBO) | Option Exercise | 4,844 | .58 | 2,809 |
| 2006-04-17 | Trautman Jay K (VP, Disc Biology & Technology) | Sale | 1,000 | 7.34 | 7,340 |
| 2006-04-17 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Sale | 5,000 | 7.34 | 36,700 |
| 2006-04-17 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Option Exercise | 5,000 | 1.00 | 5,000 |
| 2006-04-04 | Spudich James A (Director) | Sale | 2,200 | 7.61 | 16,750 |
| 2006-04-03 | Sabry James H (President and CEO) | Sale | 7,000 | 7.60 | 52,908 |
| 2006-04-03 | Sabry James H (President and CEO) | Option Exercise | 7,000 | .58 | 4,059 |
| 2006-03-30 | Blum Robert I (EVP, Corp. Development & CBO) | Sale | 4,688 | 7.06 | 33,097 |
| 2006-03-30 | Blum Robert I (EVP, Corp. Development & CBO) | Option Exercise | 4,688 | .58 | 2,719 |
| 2006-03-15 | Blum Robert I (EVP, Corp. Development & CBO) | Sale | 4,375 | 7.01 | 30,668 |
| 2006-03-15 | Blum Robert I (EVP, Corp. Development & CBO) | Option Exercise | 4,375 | .58 | 2,537 |
| 2006-03-15 | Trautman Jay K (VP, Disc Biology & Technology) | Sale | 1,000 | 7.01 | 7,010 |
| 2006-03-15 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Sale | 5,000 | 7.01 | 35,050 |
| 2006-03-15 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Option Exercise | 5,000 | 1.00 | 5,000 |
| 2006-03-02 | Spudich James A (Director) | Sale | 2,200 | 7.11 | 15,648 |
| 2006-03-01 | Sabry James H (President and CEO) | Sale | 7,000 | 7.14 | 49,980 |
| 2006-03-01 | Sabry James H (President and CEO) | Option Exercise | 7,000 | .58 | 4,059 |
| 2006-02-28 | Blum Robert I (EVP, Corp. Development & CBO) | Sale | 3,750 | 7.10 | 26,625 |
| 2006-02-28 | Blum Robert I (EVP, Corp. Development & CBO) | Option Exercise | 3,750 | .58 | 2,175 |
| 2006-02-16 | Dow Stephen M | Purchase | 5,800 | 7.49 | 43,465 |
| 2006-02-15 | Blum Robert I (EVP, Corp. Development & CBO) | Sale | 2,500 | 7.14 | 17,850 |
| 2006-02-15 | Blum Robert I (EVP, Corp. Development & CBO) | Option Exercise | 2,500 | .58 | 1,450 |
| 2006-02-15 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Sale | 5,000 | 7.20 | 36,000 |
| 2006-02-15 | Morgans David J Jr (SVP-Drug Discovery and Dev) | Option Exercise | 5,000 | 1.00 | 5,000 |
| 2006-02-15 | Dow Stephen M | Purchase | 1,200 | 7.20 | 8,640 |
| 2006-02-14 | Dow Stephen M | Purchase | 19,162 | 7.21 | 138,119 |
| 2006-02-13 | Dow Stephen M | Purchase | 13,838 | 7.22 | 99,963 |
| 2006-02-08 | Sabry James H (President and CEO) | Sale | 7,000 | 7.33 | 51,289 |
| 2006-02-08 | Sabry James H (President and CEO) | Option Exercise | 7,000 | .58 | 4,059 |
| 2006-02-03 | Spudich James A (Director) | Sale | 2,200 | 7.72 | 16,973 |
| 2005-11-08 | Sabry James H (President and CEO) | Sale | 2,000 | 8.50 | 17,000 |
| 2005-11-07 | Sabry James H (President and CEO) | Sale | 6,000 | 8.70 | 52,199 |
| 2005-11-03 | Trautman Jay K (Technology) | Sale | 32,000 | 7.44 | 238,919 |
| 2005-11-03 | Morgans David J Jr (SVP-Drug Discovery a) | Sale | 45,000 | 7.80 | 351,090 |
| 2005-11-02 | Morgans David J Jr (SVP-Drug Discovery a) | Sale | 25,000 | 7.44 | 186,074 |
| 2004-04-29 | Dow Stephen M | Purchase | 25,000 | 8.49 | 212,275 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Cytokinetics Inc (symbol CYTK,
CIK number 1061983) see
the Securities and Exchange Commission (SEC) website.
|
|
